Amneal Pharmaceuticals (AMRX) Non-Current Deferred Tax Liability (2017 - 2018)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Amneal Pharmaceuticals (AMRX) has 2 years of Non-Current Deferred Tax Liability data on record, last reported at $1.2 million in Q4 2018.

• For Q4 2018, Non-Current Deferred Tax Liability fell 52.71% year-over-year to $1.2 million; the TTM value through Dec 2018 reached $1.2 million, down 52.71%, while the annual FY2018 figure was $1.2 million, 52.71% down from the prior year.
• Non-Current Deferred Tax Liability reached $1.2 million in Q4 2018 per AMRX's latest filing, down from $1.8 million in the prior quarter.
• Across five years, Non-Current Deferred Tax Liability topped out at $2.5 million in Q4 2017 and bottomed at $1.2 million in Q4 2018.

Peer Comparison